BOSTON SCIENTIFIC CORPORATION Equity Securities, FV-NI, Gain (Loss)
BOSTON SCIENTIFIC CORPORATION (BSX) reported Equity Securities, FV-NI, Gain (Loss) of -$24.00 million for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-04.
Discontinued › Income Statement › Other Income
us-gaap:EquitySecuritiesFvNiGainLoss · last filed 2021-11-04
- BOSTON SCIENTIFIC CORPORATION equity securities, fv-ni, gain (loss) for the quarter ending 2021-09-30 was -$24.00M.
- BOSTON SCIENTIFIC CORPORATION equity securities, fv-ni, gain (loss) for the quarter ending 2021-06-30 was -$8.00M.
- BOSTON SCIENTIFIC CORPORATION equity securities, fv-ni, gain (loss) for the quarter ending 2021-03-31 was -$146.00M.
| Period end | Equity Securities, FV-NI, Gain (Loss) 3 month | Equity Securities, FV-NI, Gain (Loss) 6 month | Equity Securities, FV-NI, Gain (Loss) 9 month |
|---|---|---|---|
| 2021-09-30 | -$24.00M 10-Q · filed 2021-11-04 | -$32.00M derived: sum of 2 quarters · filed 2021-11-04 | -$178.00M 10-Q · filed 2021-11-04 |
| 2021-06-30 | -$8.00M 10-Q · filed 2021-08-06 | -$154.00M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | -$146.00M 10-Q · filed 2021-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |